Addressing Racial Bias in Healthcare AI: Elliott Green of Dandelion Health
Last month Dandelion Health, a healthcare data platform specializing in artificial intelligence...
38:16
Addressing Racial Bias in Healthcare AI: Elliott Green of Dandelion Health
Last month Dandelion Health, a healthcare data platform specializing in artificial intelligence...
38:16
An Update on the GUARDIAN Newborn Sequencing Study
Most of the leaders of genomic medicine that we speak with say we are headed toward genome...
40:01
Gene Patent Decision at 10 Years, State of Genetic Testing with Ellen Matloff, My Gene Counsel
Ten years ago this week, the Supreme Court unanimously ruled that genes could not be patented.
45:23
Proteomics Bigger than Genomics, It’s Just Taking Time, Says Jeff Hawkins, CEO, Quantum-SI
Today we feature Quantum-SI, one of the new wave of proteomics tools companies. The company...
33:56
It’s a thrilling time to be in proteomics. Today we discuss a recent paper in PLOS One...
30:37
Biden, AI, and DeSci: John Cumbers Previews SynBioBeta 2023
SynBioBeta is the largest gathering of the synthetic biology community worldwide. It’s taking...
39:16
Is This New Platform an Answer to the Reproducibility Crisis? with Guy Rohkin
Philosophers talk about various kinds of knowledge. There is knowing that something is. We...
45:55
Elegen Pioneers Long DNA Subindustry with CEO Matt Hill
Long DNA has arrived. Elegen, a new company based in San Carlos, California, is out this year...
30:24
Nevermind the $200 Genome, Element CEO Molly He Says Core Chemistry Capable of Much More
"We’re not a sequencing company," says Molly He, CEO and co-founder of Element Biosciences in our...
33:04
3D Genomics Solves Cancer Case Where Sequencing Came Up Short: Anthony Schmitt, Arima Genomics
Biology is complex, and the life science tool kit continues to expand to meet the challenge of...
26:51
New Spatial Company Maps Cell Surface Proteome without Imaging
Today we talk with Simon Fredriksson, CEO and co-founder of Pixelgen Technologies, a company just...
23:32
John Greally on His Latest Review of Epigenomics
Editor's Note: Theral's mic malfunctioned in this interview. Fortunately the not as good backup...
45:06
President of ASHG on Eugenics Apology, Diversity Initiative
Last month the American Society of Human Genetics (ASHG) took a quite remarkable step, putting...
26:15
23andMe Launches New Personalized Healthcare Initiative with Amy Sturm
23andMe occupies its own place in the world of genomics. Known for its vision to democratize...
39:52
Converting Digital to Biological: John Gill, Telesis Bio
Remember all those firsts for synthetic biology that we heard about coming from Craig Venter’s...
31:27
50% Not Tested: Precision Oncology with Jerome Madison, Invitae
Oncology has emerged as the most successful disease area for precision medicine. Last year, as...
33:38
Paul Freemont on Synthetic Biology in the UK
To begin the year, we head across the pond for an outlook on the thriving community of synthetic...
37:34
The Bioengineered Hangover Cure: Changing the Conversation around GMOs with Zack Abbott of ZBiotics
Our goal with today’s show was twofold: bring you a practical holiday gift idea and to take you...
40:31
What Is the State of COVID this Winter? with Mara Aspinall, Rockefeller Foundation
Winter is here. In America, we're just back from the Thanksgiving holiday when many of us travel...
34:29
Proteomics at Scale Empowers Genomics in New Ways: Dale Yuzuki, Olink
It’s the age of multi omics. Or multi comics, if you don't catch spell check. A few weeks ago...
52:30